Benin Management Corp Abb Vie Inc. Transaction History

Benin Management Corp

$315 Million
Q1 2024

A detailed history of Benin Management Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Benin Management Corp holds 1,472 shares of ABBV stock, worth $246,192. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,472

Previous 1,436 2.51%

Holding current value

$246,192

Previous $222,000 20.72%

% of portfolio

0.09%

Previous 0.08%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 15, 2024	BUY	$159.82 - $182.1 $5,753 - $6,555	36 Added 2.51%	1,472 $268,000
Q4 2023 Jan 25, 2024	BUY	$137.6 - $154.97 $197,593 - $222,536	1,436 New	1,436 $222,000
Q1 2021 Apr 27, 2021	SELL	$102.3 - $112.62 $20,460 - $22,524	-200 Reduced 3.31%	5,850 $633,000
Q3 2020 Oct 22, 2020	SELL	$85.91 - $100.83 $42,955 - $50,415	-500 Reduced 7.63%	6,050 $530,000
Q2 2020 Jul 22, 2020	SELL	$73.37 - $98.18 $7,337 - $9,818	-100 Reduced 1.5%	6,550 $643,000

Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $6,450 - $9,779	100 Added 1.53%	6,650 $507,000
Q4 2019 Jan 23, 2020	SELL	$72.13 - $90.25 $79,343 - $99,275	-1,100 Reduced 14.38%	6,550 $580,000
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $9,447 - $11,358	150 Added 2.0%	7,650 $579,000
Q2 2019 Jul 31, 2019	BUY	$65.7 - $83.98 $98,550 - $125,970	1,500 Added 25.0%	7,500 $545,000
Q4 2018 Jan 22, 2019	BUY	$77.85 - $96.01 $11,677 - $14,401	150 Added 2.56%	6,000 $553,000
Q1 2018 Apr 24, 2018	BUY	$92.01 - $123.21 $46,005 - $61,605	500 Added 9.35%	5,850 $554,000
Q4 2017 Jan 18, 2018	SELL	$89.56 - $98.21 $89,560 - $98,210	-1,000 Reduced 15.75%	5,350 $517,000
Q3 2017 Oct 13, 2017	BUY	$69.85 - $89.22 $443,547 - $566,547	6,350	6,350 $564,000

Others Institutions Holding ABBV

# of Institutions

3,653

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $296B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Benin Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Benin Management Corp with notifications on news.

Account

Benin Management Corp Abb Vie Inc. Transaction History